BioCentury
ARTICLE | Company News

Aventis Behring receives European approval

August 10, 2000 7:00 AM UTC

Aventis Behring (King of Prussia, Penn.) received marketing approval in Europe for its Helixate NexGen recombinant Factor VIII formulation to treat hemophilia A. The product, which is more concentrate...